Back to results
US 8,883,803 B2Granted
Inhibitors of Bruton's tyrosine kinase for the treatment of solid tumors
AssigneePharmacyclics, Inc.
InventorsLee Honigberg, Erik Verner, Joseph Buggy, David Loury, Wei Chen
Life of this patent
Estimating the term…
Abstract
Described herein are irreversible Btk inhibitor compounds, and methods for using such irreversible inhibitors in the treatment of diseases and disorders characterized by the presence or development of solid tumors.
Claims9
A method for treating a carcinoma in an individual comprising administering to the individual having a carcinoma, a compound having the structure:
- or a pharmaceutically acceptable salt thereof, wherein the carcinoma is breast cancer.
Dependencies are inferred from the claim text.